tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market
Holding VIR?
Track your performance easily

Vir Biotechnology (VIR) Cash flow

1,189 Followers

Vir Biotechnology Cash Flow

VIR's free cash flow for Q4 2023 was $―. For the 2023 fiscal year, VIR's free cash flow was decreased by $-2.40B and operating cash flow was $-107.93M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -778.80M$ -778.78M$ 1.66B$ -47.59M$ -190.94M$ -129.63M
Investing Cash Flow
$ 164.63M$ 164.63M$ -1.19B$ -140.81M$ -9.86M$ -256.16M
Financing Cash Flow
$ 7.48M$ 7.48M$ 34.76M$ 100.33M$ 529.47M$ 449.24M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 2.18B$ 261.29M$ 867.97M$ 363.42M$ 451.49M$ 122.82M
Income Tax Paid Supplemental Data
$ 2.68M$ 2.68M$ 252.03M---
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 4.28M$ 4.28M$ 3.22M$ 2.30M$ 529.91M$ 443.75M
Issuance Of Debt
$ -287.00K$ -287.00K$ -260.00K$ -259.00K$ 0.00$ 4.47M
Repayment Of Debt
$ -134.00K$ -287.00K$ -260.00K$ -259.00K$ -250.00K$ -95.00K
Free Cash Flow
$ -531.37M$ -800.36M$ 1.60B$ -69.41M$ -197.49M$ -138.57M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Vir Biotechnology Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis